US-CONGRESS HR9396: Prior Authorization Accountability Act
The Prior Authorization Accountability Act aims to enhance transparency and accountability in the prior authorization process for prescription drugs, impacting pharmacies and healthcare providers.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 21, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the current text.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New requirements for transparency and accountability in the prior authorization process for controlled substances.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies.
What you must do
Prepare to comply with new transparency measures regarding prior authorizations for prescriptions.
Deadline
Not specified in the current text.
Source: https://www.congress.gov/bill/119th-congress/house-bill/9396
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Guidance: Compounding Animal Drugs from Bulk Drug Substances: Compounding under CGMP in Federally-Registered Facilities
- Decision and Order: Atlantic Treatment Center, LLC
- NC pharmacists can now dispense birth control without a prescription. How it works. - Raleigh News & Observer
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments